Sale of 13 shares at $10.56 per share.
Reporting Person Bowen Matthew · Officer Title Principal Accounting Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001193125-26-415540 · filed 2026-10-06 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Monte Rosa Therapeutics, Inc. (GLUE)." Disclosed 2026-10-06. https://desqlong.com/cards/0001193125-26-415540-1 (retrieved 2026-10-07).